Literature DB >> 19381638

Pulmonary complications in human T-cell lymphotropic virus type 1 carriers with Sjögren's syndrome, three case reports and literature review.

Hui Yu1, Futoshi Higa, Ichiro Yamadori, Satomi Yara, Yasushi Tanimoto, Shusaku Haranaga, Masao Tateyama, Jiro Fujita, Mitsune Tanimoto, Huiping Li.   

Abstract

In this study, we report three cases diagnosed with human T-cell lymphotropic virus type 1 (HTLV-1) and Sjögren’s syndrome (SS) who developed pulmonary complications. Radiologic and pathologic findings were evaluated. Although the histologic diagnosis was considered to be hypersensitivity pneumonitis in case 1, and discordant usual interstitial pneumonia (UIP) in cases 2 and 3, lymphocytic alveolitis was observed in all cases. We also did a literature review and concluded that, although the pathologic diagnosis of pulmonary complications in HTLV-1 carriers with SS may vary, lymphocytic infiltrations are commonly observed.

Entities:  

Mesh:

Year:  2009        PMID: 19381638     DOI: 10.1007/s00296-009-0921-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

1.  HTLV-1 and polymyositis in Jamaica.

Authors:  O S Morgan; P Rodgers-Johnson; C Mora; G Char
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

2.  Adult T-cell leukemia with a solitary lung mass.

Authors:  T Okura; R Tanaka; H Shibata; H Kukita
Journal:  Chest       Date:  1992-05       Impact factor: 9.410

3.  Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals.

Authors:  Y Higashiyama; S Katamine; S Kohno; H Mukae; S Hino; T Miyamoto; K Hara
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

4.  Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathy.

Authors:  Caroline Pot; Carlo Chizzolini; Natalia Vokatch; Jean-Marie Tiercy; Camillo Ribi; Theodor Landis; Fabienne Perren
Journal:  Arch Neurol       Date:  2006-09

5.  Human T-cell lymphotropic virus type I (HTLV-1) associated myelopathy and Sjögren's syndrome representing pulmonary nodular amyloidosis and multiple bullae: Report of an autopsy case.

Authors:  Tomoko Seguchi; Yuka Kyoraku; Kazuko Saita; Toshihiko Ihi; Miyuki Nagai; Yutaka Akiyama; Hiroshi Itoh; Hiroaki Kataoka
Journal:  Virchows Arch       Date:  2006-04-12       Impact factor: 4.064

Review 6.  Human T-cell lymphotropic virus type 1-associated myelopathy, Sjögren syndrome, and lymphocytic pneumonitis.

Authors:  A Kompoliti; B Gage; L Sharma; J C Daniels
Journal:  Arch Neurol       Date:  1996-09

7.  Non-Hodgkin lymphoma in Jamaica and its relation to adult T-cell leukemia-lymphoma.

Authors:  W N Gibbs; W S Lofters; M Campbell; B Hanchard; L LaGrenade; B Cranston; J Hendriks; E S Jaffe; C Saxinger; M Robert-Guroff
Journal:  Ann Intern Med       Date:  1987-03       Impact factor: 25.391

Review 8.  An HTLV-I vaccine: why, how, for whom?

Authors:  G de Thé; R Bomford
Journal:  AIDS Res Hum Retroviruses       Date:  1993-05       Impact factor: 2.205

9.  HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease.

Authors:  S Jacobson; D E McFarlin; S Robinson; R Voskuhl; R Martin; A Brewah; A J Newell; S Koenig
Journal:  Ann Neurol       Date:  1992-11       Impact factor: 10.422

10.  Clinicopathologic characteristics of the lungs of patients with human T cell lymphotropic virus type 1-associated myelopathy.

Authors:  K Sugisaki; T Tsuda; T Kumamoto; S Akizuki
Journal:  Am J Trop Med Hyg       Date:  1998-06       Impact factor: 2.345

View more
  1 in total

Review 1.  Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection.

Authors:  Lloyd Einsiedel; Fabian Chiong; Hubertus Jersmann; Graham P Taylor
Journal:  Retrovirology       Date:  2021-01-06       Impact factor: 4.602

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.